Ultimo aggiornamento :
19/11/2024
Beta-bloccante   Propranolol hydrochloride  
Soluzione orale
Iniezione
Stabilità dei preparati farmaceutici Stabilità in miscela Fattori che influenzano la stabilità Compatibilità Bibliografia pdf
   Struttura chimica  

Soluzione orale
Bibliografia   Soluzione orale   Bibliografia : Propranolol hydrochloride  
tipo pubblicazione
2477 Rivista Henry DW, Repta AJ, Smith FM, White SJ.
Stability of propranolol hydrochloride suspension compounded from tablets
Am J Hosp Pharm 1986 ; 43: 1492-1495.
2504 Rivista Rooney M, Creurer I.
Stability of propranolol hydrochloride suspension and solution
Am J Hosp Pharm 1988 ; 45: 530-531.
2513 Rivista Das Gupta V, Stewart KR.
Stability of propranolol hydrochloride suspension and solution compounded from injection or tablets
Am J Hosp Pharm 1987 ; 44: 360-361.
3356 Rivista Geiger C M, Voudrie M A, Sorenson B.
Stability of Propranolol Hydrochloride in SyrSpend SF.
Int J Pharm Compound 2012 ; 16, 6 : 513-515.
3410 Rivista Ensom M.H, Kendrick J, Rudolph S, Decarie D.
Stability of Propranolol in Extemporaneously Compounded Suspensions
Can J Hosp Pharm 2013 ; 66, 2: 118-124.
3996 Rivista Dijkers E,Nanhekhan V,Thorissen A.
Updated Stability Data of Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSprend SF and Minoxidil in Espumil.
Int J Pharm Compound 2017 ; 21,3 : 240-241.
4177 Rivista Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2018 ;22,6:516-526

  Mentions Légales